Banyan Capital Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.8M | Sell |
38,533
-555
| -1% | -$146K | 4.69% | 9 |
|
|
2026
Q1 | $10.4M | Sell |
39,088
-1,009
| -3% | -$273K | 4.49% | 9 |
|
|
2025
Q4 | $10.1M | Sell |
40,097
-287
| -0.7% | -$76.2K | 4.37% | 11 |
|
|
2025
Q3 | $11.6M | Buy |
40,384
+1,241
| +3% | +$332K | 5.27% | 8 |
|
|
2025
Q2 | $10.3M | Buy |
39,143
+923
| +2% | +$225K | 5.28% | 9 |
|
|
2025
Q1 | $8.9M | Buy |
38,220
+126
| +0.3% | +$30.6K | 5.02% | 11 |
|
|
2024
Q4 | $8.74M | Sell |
38,094
-5
| -0% | -$1.15K | 5.24% | 11 |
|
|
2024
Q3 | $8.51M | Buy |
38,099
+318
| +0.8% | +$69.9K | 4.93% | 12 |
|
|
2024
Q2 | $7.69M | Buy |
37,781
+2,925
| +8% | +$595K | 4.65% | 12 |
|
|
2024
Q1 | $7.62M | Buy |
34,856
+31
| +0.1% | +$6.83K | 4.32% | 12 |
|
|
2023
Q4 | $7.92M | Buy |
34,825
+56
| +0.2% | +$11.8K | 4.85% | 11 |
|
|
2023
Q3 | $6.99M | Sell |
34,769
-5,649
| -14% | -$1.19M | 4.54% | 11 |
|
|
2023
Q2 | $8.38M | Buy |
40,418
+76
| +0.2% | +$14.7K | 5.54% | 11 |
|
|
2023
Q1 | $7.95M | Sell |
40,342
-216
| -0.5% | -$44.4K | 5.8% | 10 |
|
|
2022
Q4 | $8.21M | Buy |
40,558
+17
| +0% | +$3.32K | 6.1% | 9 |
|
|
2022
Q3 | $7.13M | Buy |
40,541
+2,897
| +8% | +$593K | 5.31% | 11 |
|
|
2022
Q2 | $7.58M | Hold |
37,644
| – | – | 5.11% | 12 |
|
|
2022
Q1 | $8.53M | Hold |
37,644
| – | – | 4.97% | 12 |
|
|
2021
Q4 | $10.2M | Sell |
37,644
-34
| -0.1% | -$8.42K | 5.87% | 9 |
|
|
2021
Q3 | $9.11M | Sell |
37,678
-286
| -0.8% | -$72.1K | 5.8% | 10 |
|
|
2021
Q2 | $9M | Sell |
37,964
-80
| -0.2% | -$18.2K | 5.6% | 10 |
|
|
2021
Q1 | $8.34M | Sell |
38,044
-488
| -1% | -$97.9K | 5.52% | 11 |
|
|
2020
Q4 | $6.74M | Sell |
38,532
-50
| -0.1% | -$8.64K | 4.85% | 12 |
|
|
2020
Q3 | $6.24M | Sell |
38,582
-376
| -1% | -$59.6K | 5.2% | 12 |
|
|
2020
Q2 | $5.56M | Sell |
38,958
-280
| -0.7% | -$38.7K | 5.12% | 10 |
|
|
2020
Q1 | $4.26M | Buy |
39,238
+5,700
| +17% | +$821K | 4.52% | 13 |
|
|
2019
Q4 | $4.87M | Sell |
33,538
-189
| -0.6% | -$27.3K | 4.25% | 13 |
|
|
2019
Q3 | $4.87M | Sell |
33,727
-1,612
| -5% | -$235K | 4.61% | 13 |
|
|
2019
Q2 | $5.25M | Hold |
35,339
| – | – | 4.93% | 12 |
|
|
2019
Q1 | $4.64M | Sell |
35,339
-454
| -1% | -$55.9K | 4.74% | 13 |
|
|
2018
Q4 | $3.88M | Buy |
+35,793
| New | +$4.79M | 4.35% | 13 |
|
Other funds holding LH
Banyan Capital Management's LH Position: Q2 2026 in Review
Banyan Capital Management reduced its Labcorp (LH) stake by 1.4% in Q2 2026, selling an estimated $146K and leaving 38,533 shares worth $10.8M. The position accounts for 4.69% of the portfolio, ranked #9.
Banyan Capital Management first reported a position in LH in Q4 2018 and has held it in 31 quarters since. The position peaked at $11.6M in Q3 2025. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Banyan Capital Management held 38,533 shares of Labcorp worth $10.8M as of Q2 2026.
- Banyan Capital Management sold 555 Labcorp shares in Q2 2026, an estimated $146K.
- Labcorp made up 4.69% of Banyan Capital Management's portfolio in Q2 2026, its #9 holding.
- Banyan Capital Management first reported a position in Labcorp in Q4 2018 and has held it in 31 quarters since.
- Banyan Capital Management's Labcorp position peaked at $11.6M in Q3 2025.
- 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Banyan Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.